All studies
Endocrinology · EHR · Taiwan

Hu 2024

Diabetes

ITTSuperiorityAcademia1/5 disclosures
Comparisons
2
In the analysis
2
all comparisons pooled
Target trials
2
Emulations reported
1
4 treatments

Comparisons

2 shown
Randomized trialEmulation
Outcome & target trialTrial vs emulationOn a shared scaleAgreement
Anemia event occurrence or anemia treatment initiation
vs CREDENCE·HR·Efficacy
0.650.55–0.77
0.760.64–0.90
overlapMajor deviation1.28 SE apart
Anemia event occurrence or anemia treatment initiation
vs DAPA-CKD·HR·Efficacy
0.390.31–0.48
0.800.72–0.90
no overlapMajor deviation5.74 SE apart

Design and methods

Estimand
ITT
Design hypothesis
Superiority
Matching / weighting
PS matching
Analysis method
Cox PH
Missing data
Missing as no measurment
Covariates adjusted
37
DAG
No
QBA
No

Data and sample

Data type
EHR
Data sources
7
Geography
Taiwan
Eligible sample
13799
Treated
12331
Control
1468
Emulations
1
Treatments compared
4

Transparency

1/5
Protocol
No pre-registration
Preprint
No preprint
Data availability
Unavailable
Code availability
Unavailable
Conflicts of interest
Declared: None
Funding
Not declared

The 0-5 count records which disclosures are present. It is not a quality score: a data link does not establish that the data are reusable.

Provenance

Review key
2024_Hu_Diabetes
DOI
https://dx.doi.org/10.1001/jamanetworkopen.2024.0946
Affiliations
National Cheng Kung University, Keelung Chang Gung Memorial Hospital
Sector
Academia
Target trials (study level)
CREDENCE
Registration
NCT02065791